CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 43.86% | -21.90% | — | |
| 2 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 30.07% | — | — | |
| 3 | ✓ | Evelo Biosciences INC | Stock-Other | 11.58% | — | — | |
| 4 | DNLI | Denali Therapeutics INC | Stock-Other | 9.00% | — | — | |
| 5 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 2.80% | — | — | |
| 6 | QTRX | Quanterix CORP | Stock-Other | 1.82% | — | — | |
| 7 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 0.87% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QTRX | Quanterix CORP | -1.1% | — | Unchanged |
| 2 | SYRSEUR | Syros Pharmaceuticals INC | -1.7% | — | Unchanged |
| 3 | ✓ | Evelo Biosciences INC | -3.1% | — | Unchanged |
| 4 | MCRB1EUR | Seres Therapeutics INC | -3.6% | — | Unchanged |
| 5 | DNLI | Denali Therapeutics INC | -3.8% | — | Unchanged |
| 6 | RUBYUSD | Rubius Therapeutics INC | -30.7% | — | Unchanged |
| 7 | MRNA | Moderna INC | — | NEW | New buy |